GDC-0339
Catalog No. A20920
GDC-0339 is a potent, orally bioavailable and well tolerated pan-Pim kinase inhibitor, with Kis of 0.03 nM, 0.1 nM and 0.02 nM for Pim1, Pim2 and Pim3, respectively. GDC-0339 is discovered as a potential treatment of multiple myeloma.
Catalog Num | A20920 |
---|---|
M. Wt | 465.5 |
Formula | C20H22F3N7OS |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1428569-85-0 |
Synonyms | GDC0339, GDC 0339 |
SMILES | FC1=CC=CC(F)=C1C2=NC(C(NC3=C(N4CC[C@@H](F)[C@H](N)CC4)N(C)N=C3)=O)=C(N)S2 |
GDC-0339 is a potent, orally bioavailable and well tolerated pan-Pim kinase inhibitor, with Kis of 0.03 nM, 0.1 nM and 0.02 nM for Pim1, Pim2 and Pim3, respectively. GDC-0339 is discovered as a potential treatment of multiple myeloma.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.48 mL | 107.41 mL | 214.82 mL |
0.5 mM | 4.3 mL | 21.48 mL | 42.96 mL |
1 mM | 2.15 mL | 10.74 mL | 21.48 mL |
5 mM | 0.43 mL | 2.15 mL | 4.3 mL |
*The above data is based on the productmolecular weight 465.5. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.